Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease.

Roberts AW, Seymour JF, Brown JR, Wierda WG, Kipps TJ, Khaw SL, Carney DA, He SZ, Huang DC, Xiong H, Cui Y, Busman TA, McKeegan EM, Krivoshik AP, Enschede SH, Humerickhouse R.

J Clin Oncol. 2012 Feb 10;30(5):488-96. doi: 10.1200/JCO.2011.34.7898. Epub 2011 Dec 19.

PMID:
22184378
[PubMed - indexed for MEDLINE]
2.

Potential therapeutic applications of oblimersen in CLL.

Koziner B.

Oncology (Williston Park). 2004 Nov;18(13 Suppl 10):32-8. Review.

PMID:
15651175
[PubMed - indexed for MEDLINE]
3.

A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia.

Zhang LN, Li JY, Xu W.

Cancer Gene Ther. 2013 Jan;20(1):1-7. doi: 10.1038/cgt.2012.84. Epub 2012 Nov 23. Review.

PMID:
23175245
[PubMed - indexed for MEDLINE]
4.

Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.

Dennie TW, Kolesar JM.

Clin Ther. 2009;31 Pt 2:2290-311. doi: 10.1016/j.clinthera.2009.11.031. Review.

PMID:
20110042
[PubMed - indexed for MEDLINE]
5.

Pharmacokinetic evaluation of oblimersen sodium for the treatment of chronic lymphocytic leukemia.

Advani PP, Paulus A, Masood A, Sher T, Chanan-Khan A.

Expert Opin Drug Metab Toxicol. 2011 Jun;7(6):765-74. doi: 10.1517/17425255.2011.579105. Epub 2011 Apr 27. Review.

PMID:
21521129
[PubMed - indexed for MEDLINE]
6.

The role of high-dose corticosteroids in the treatment of chronic lymphocytic leukemia.

Smolej L.

Expert Opin Investig Drugs. 2012 Jul;21(7):1009-17. doi: 10.1517/13543784.2012.690393. Epub 2012 May 23. Review.

PMID:
22616646
[PubMed - indexed for MEDLINE]
7.

DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemia.

Frankel AE, Fleming DR, Powell BL, Gartenhaus R.

Expert Opin Biol Ther. 2003 Feb;3(1):179-86. Review.

PMID:
12718740
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk